Volume 12, Number 10—October 2006
Research
Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children
Table 3
Events | Most likely estimate | Range for sensitivity analysis |
---|---|---|
Episode of influenza | 0.005 | 0.002-0.009 |
Otitis media | 0.042 | 0.023-0.065 |
Nonhospitalized complications (pneumonia) | 0.046 | 0.027-0.071 |
Hospitalization, pneumonia | 0.076 | 0.054-0.100 |
Anaphylaxis | 0.020 | 0.006-0.041 |
Guillain-Barré syndrome | 0.141 | 0.092-0.199
*Quality adjustments are included in model as a one-time decrement in utility for each temporary health state. For example, an episode of influenza results in a 1-time loss of 0.005 quality-adjusted life years (QALYs). Utility losses were calculated by dividing discounted time-traded off by respondent's discounted life expectancy. See appendix for references. |
*Quality adjustments are included in model as a one-time decrement in utility for each temporary health state. For example, an episode of influenza results in a 1-time loss of 0.005 quality-adjusted life years (QALYs). Utility losses were calculated by dividing discounted time-traded off by respondent's discounted life expectancy. See appendix for references.
†Average life span used to calculate total QALYs lost due to lifelong sequelae and death was 77.9–78.2 years, depending on child's current age.